|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1996-7-31
|
|
pubmed:abstractText |
To evaluate whether tamoxifen enhances the cytotoxicity of chemotherapeutic agents on bladder cancer cells, and the possible mechanism(s) of action.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0007-1331
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
76-85
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8653321-Administration, Intravesical,
pubmed-meshheading:8653321-Antimetabolites, Antineoplastic,
pubmed-meshheading:8653321-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8653321-Base Sequence,
pubmed-meshheading:8653321-Cell Division,
pubmed-meshheading:8653321-Drug Resistance, Multiple,
pubmed-meshheading:8653321-Drug Resistance, Neoplasm,
pubmed-meshheading:8653321-Humans,
pubmed-meshheading:8653321-Molecular Sequence Data,
pubmed-meshheading:8653321-P-Glycoprotein,
pubmed-meshheading:8653321-Rhodamine 123,
pubmed-meshheading:8653321-Rhodamines,
pubmed-meshheading:8653321-Tamoxifen,
pubmed-meshheading:8653321-Tumor Cells, Cultured,
pubmed-meshheading:8653321-Urinary Bladder Neoplasms,
pubmed-meshheading:8653321-Verapamil
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
|
|
pubmed:affiliation |
Department of Urology, National Taiwan University Hospital, Taipei, Republic of China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
